Stage III Cutaneous Melanoma AJCC v7

general

Stage IIIB includes: (T1-4b, N1a, M0); (T1-4b, N2a, M0); (T1-4a, N1b, M0); (T1-4a, N2b, M0); (T1-4a, N2c, M0). T1-4b: Ulcerated cutaneous melanoma of any thickness. T1-4a: Non-ulcerated cutaneous melanoma of any thickness. N1a: Cutaneous melanoma with micrometastasis in one regional lymph node. N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes. N1b: Cutaneous melanoma with macrometastasis in one regional lymph node. N2b: Cutaneous melanoma with macrometastases in 2-3

78

Centers

327

Active Trials

$3.8B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Stage III Cutaneous Melanoma AJCC v7(78)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.2
2
High-Volume Research Center
72.2
3
High-Volume Research Center
72.2
4
NCI Comprehensive
Active Research Program
67.0
5
NCI Comprehensive
Active Research Program
67.0
6
NCI Comprehensive
Active Research Program
67.0
767.0
8
NCI Comprehensive
Active Research Program
67.0
9
NCI Comprehensive
Active Research Program
67.0
10
NCI Comprehensive
Active Research Program
67.0
11
NCI Clinical
Active Research Program
67.0
12
NCI Comprehensive
Active Research Program
67.0
13
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
67.0
14
Active Research Program
67.0
15
Active Research Program
67.0
16
NCI Comprehensive
Active Research Program
57.1
17
NCI Comprehensive
Active Research Program
57.1
18
NCI Comprehensive
Active Research Program
57.1
19
NCI Comprehensive
Active Research Program
57.1
20
NCI Comprehensive
Active Research Program
57.1
21
NCI Comprehensive
Active Research Program
57.1
22
NCI Comprehensive
Active Research Program
57.1
23
NCI Comprehensive
Active Research Program
57.1
24
NCI Clinical
Active Research Program
57.1
25
NCI Comprehensive
Active Research Program
57.1
26
Active Research Program
57.1
27
Active Research Program
57.1
28
NCI Clinical
Active Research Program
57.1
29
Active Research Program
57.1
30
Active Research Program
57.1
31
Active Research Program
57.1
32
NCI Comprehensive
Active Research Program
40.9
33
NCI Comprehensive
Active Research Program
40.9
34
NCI Comprehensive
Active Research Program
40.9
35
NCI Comprehensive
Active Research Program
40.9
36
NCI Comprehensive
Active Research Program
40.9
37
NCI Comprehensive
Active Research Program
40.9
38
NCI Comprehensive
Active Research Program
40.9
39
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
40.9
40
NCI Comprehensive
Active Research Program
40.9
41
NCI Comprehensive
Active Research Program
40.9
42
NCI Comprehensive
Active Research Program
40.9
43
NCI Clinical
Active Research Program
40.9
44
NCI Comprehensive
Active Research Program
40.9
45
NCI Comprehensive
Active Research Program
40.9
46
NCI Comprehensive
Active Research Program
40.9
47
NCI Comprehensive
Active Research Program
40.9
48
Active Research Program
40.9
49
NCI Comprehensive
Active Research Program
40.9
50
NCI Comprehensive
Active Research Program
40.9
51
NCI Comprehensive
Active Research Program
40.9
52
NCI Comprehensive
Active Research Program
40.9
53
Active Research Program
40.9
54
NCI Basic_laboratory
Active Research Program
40.9
55
Active Research Program
40.9
56
Active Research Program
40.9
57
Active Research Program
40.9
58
Active Research Program
40.9
59
Active Research Program
40.9
60
Active Research Program
40.9
61
Active Research Program
40.9
62
NCI Comprehensive
29.3
63
NCI Comprehensive
29.3
6429.3
65
66
67
NCI Comprehensive
68
NCI Comprehensive
69
NCI Comprehensive
70
71
72
73
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
74
75
76
77
78

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →